M Toti

947 total citations
26 papers, 566 citations indexed

About

M Toti is a scholar working on Epidemiology, Hepatology and Genetics. According to data from OpenAlex, M Toti has authored 26 papers receiving a total of 566 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Epidemiology, 14 papers in Hepatology and 5 papers in Genetics. Recurrent topics in M Toti's work include Hepatitis B Virus Studies (15 papers), Hepatitis C virus research (9 papers) and Liver Disease Diagnosis and Treatment (7 papers). M Toti is often cited by papers focused on Hepatitis B Virus Studies (15 papers), Hepatitis C virus research (9 papers) and Liver Disease Diagnosis and Treatment (7 papers). M Toti collaborates with scholars based in Italy. M Toti's co-authors include Ferruccio Bonino, Patrizia Farci, C Lavarini, Tommaso Stroffolini, P Piantino, Antonina Smedile, O Crivelli, Mario Rizzetto, Nicola Caporaso and Roberto Romi and has published in prestigious journals such as The Lancet, Gastroenterology and Hepatology.

In The Last Decade

M Toti

25 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
M Toti Italy 12 404 378 92 74 23 26 566
Nicole Simon France 10 406 1.0× 440 1.2× 24 0.3× 106 1.4× 35 1.5× 12 577
I. K. Kuramoto United States 11 323 0.8× 448 1.2× 14 0.2× 171 2.3× 26 1.1× 20 525
E. D'Hondt Spain 14 317 0.8× 486 1.3× 77 0.8× 293 4.0× 56 2.4× 22 642
B Galanti Italy 11 253 0.6× 193 0.5× 33 0.4× 114 1.5× 59 2.6× 52 460
Joëlle Lerable France 9 316 0.8× 299 0.8× 11 0.1× 164 2.2× 9 0.4× 14 474
J. Mellor United Kingdom 9 708 1.8× 788 2.1× 16 0.2× 202 2.7× 89 3.9× 14 952
Kioko Takei Brazil 11 97 0.2× 87 0.2× 30 0.3× 39 0.5× 27 1.2× 23 287
Iwao Ariyama Japan 11 278 0.7× 273 0.7× 14 0.2× 65 0.9× 28 1.2× 21 457
Pierre Berthelot France 9 272 0.7× 250 0.7× 7 0.1× 60 0.8× 20 0.9× 10 447
Prapan Jutavijittum Thailand 14 464 1.1× 344 0.9× 8 0.1× 78 1.1× 25 1.1× 28 586

Countries citing papers authored by M Toti

Since Specialization
Citations

This map shows the geographic impact of M Toti's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M Toti with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M Toti more than expected).

Fields of papers citing papers by M Toti

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M Toti. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M Toti. The network helps show where M Toti may publish in the future.

Co-authorship network of co-authors of M Toti

This figure shows the co-authorship network connecting the top 25 collaborators of M Toti. A scholar is included among the top collaborators of M Toti based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M Toti. M Toti is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Santantonio, Teresa, M. Fasano, Evangelista Sagnelli, et al.. (2014). Acute hepatitis C: A 24-week course of pegylated interferon alpha-2b versus a 12-week course of pegylated interferon alpha-2b alone or with ribavirin. Hepatology. 59(6). 2101–2109. 28 indexed citations
2.
Cusi, Maria Grazia, Alberto Roggi, Chiara Terrosi, Gianni Gori Savellini, & M Toti. (2011). Retrospective Diagnosis of West Nile Virus Infection in a Patient with Meningoencephalitis in Tuscany, Italy. Vector-Borne and Zoonotic Diseases. 11(11). 1511–1512. 6 indexed citations
3.
Sposato, Bruno, et al.. (2010). Influenza A H1N1 and severe asthma exacerbation.. PubMed. 14(5). 487–90. 8 indexed citations
4.
Sposato, Bruno, et al.. (2010). Mesalazine-Induced Multi-Organ Hypersensitivity. Clinical Drug Investigation. 30(6). 413–417. 16 indexed citations
5.
Sposato, Bruno, et al.. (2010). Mesalazine-Induced Multi-Organ Hypersensitivity. Clinical Drug Investigation. 1–1. 5 indexed citations
6.
Vannacci, Alfredo, Francesco Lapi, Eugenia Gallo, et al.. (2009). A case of hepatitis associated with long-term use of Cimicifuga racemosa.. PubMed. 15(3). 62–3. 11 indexed citations
7.
Lazzarini, Luca, M Toti, Paolo Fabris, et al.. (2008). Clinical Features of Bacterial Meningitis in Italy: a Multicenter Prospective Observational Study. Journal of Chemotherapy. 20(4). 478–487. 8 indexed citations
8.
Santantonio, T., Emanuela Medda, Carlo Ferrari, et al.. (2006). Risk Factors and Outcome among a Large Patient Cohort with Community-Acquired Acute Hepatitis C in Italy. Clinical Infectious Diseases. 43(9). 1154–1159. 80 indexed citations
9.
Taliani, Gloria, Carlo Ferrari, Antonio Aceti, et al.. (2006). Pegylated Interferon Alfa-2b Plus Ribavirin in the Retreatment of Interferon-Ribavirin Nonresponder Patients. Gastroenterology. 130(4). 1098–1106. 65 indexed citations
10.
Caudai, C., et al.. (2004). Longitudinal study in HIV/HCV-coinfected HAART-naive patients and role of HCV genotype. Journal of Clinical Virology. 32(2). 151–155. 6 indexed citations
11.
Rapicetta, M., et al.. (2000). Molecular evolution of HCV genotype 2c persistent infection following mother-to-infant transmission. Archives of Virology. 145(5). 965–977. 7 indexed citations
12.
Sabatinelli, Guido, et al.. (1998). Malaria in Maremma, Italy. The Lancet. 351(9111). 1246–1247. 92 indexed citations
13.
Incandela, L., et al.. (1994). [Incidence and prevalence of anti-HVC antibodies and HBV markers in patients undergoing extracorporeal hemodialysis].. PubMed. 85(10). 505–9. 3 indexed citations
14.
Sagnelli, Evangelista, Tommaso Stroffolini, Antonio Ascione, et al.. (1992). The epidemiology of hepatitis delta infection in Italy. Journal of Hepatology. 15(1-2). 211–215. 54 indexed citations
15.
Lavarini, C, Patrizia Farci, E. Chiaberge, et al.. (1983). IgM antibody against hepatitis B core antigen (IgM anti-HBc): diagnostic and prognostic significance in acute HBsAg positive hepatitis.. BMJ. 287(6401). 1254–1256. 19 indexed citations
16.
Rizzi, Rita, et al.. (1983). HBsAg/IgM complexes in serum of HBsAg carriers: partial characterization and clinical significance.. PubMed. 62(2). 137–44.
17.
Farci, Patrizia, Antonina Smedile, C Lavarini, et al.. (1983). Delta hepatitis in inapparent carriers of hepatitis B surface antigen. A disease simulating acute hepatitis B progressive to chronicity.. PubMed. 85(3). 669–73. 55 indexed citations
18.
Toti, M, et al.. (1983). Complexes between hbsag and igm in serum of patients with acute hepatitis. Journal of Medical Virology. 11(2). 139–145. 11 indexed citations
19.
Rizzi, Roberto, M Toti, P Almi, et al.. (1983). Complexes of hepatitis B surface antigen and immunoglobulin M in the sera of patients with hepatitis B virus infection. Infection and Immunity. 41(3). 950–958. 19 indexed citations
20.
Mazzanti, Roberto, A Arcangeli, A. Auteri, et al.. (1978). [The anti-steatosic effect of sulfo-adenosylmethionine (SAMe) in various forms of chronic hepatopathy. Multicentric research].. PubMed. 69(48). 3283–92. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026